ERAP1 and cancer: Several haplotypes have been demonstrated to impact the antigenic peptide repertoire, potentially resulting in autoimmune disease6 and possibly as a mechanism for cancer cells to evade immune detection.7, 8 Mice express an orthologue of ERAP1 with 84% sequence identity, but do not possess the ERAP2 gene.9